TheraRadar
← Back
Data updated: Mar 29, 2026

PHARMACOSMOS

OncologyCardiovascular
Pharma

PHARMACOSMOS is a pharmaceutical company focused on Oncology, Cardiovascular. Key products include MONOFERRIC.

2020
Since
2
Drugs
-
Trials
2
Approved (2yr)

Key Drugs

MONOFERRIC
ferric derisomaltose
Transferrin 2 indications · 2020
COSELA
trilaciclib dihydrochloride
Oncology
CDK4 2 indications · 2021

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

COSELA 2025-08-25
Labeling
MONOFERRIC 2024-08-01
Labeling
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 75%
1 drugs Phase 3: 1 Phase 1: 2
Cardiovascular 25%
0 drugs Phase 3: 1

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Novartis big-pharma
Oncology, Cardiovascular
Merck big-pharma
Oncology, Cardiovascular
Baxter specialty
Cardiovascular, Oncology
Johnson & Johnson big-pharma
Oncology, Cardiovascular
Bayer big-pharma
Oncology, Cardiovascular